Abstract: The disclosures herein provide compounds of formula I or its pharmaceutical acceptable salts as well as polymorphs enantiomers stereoisomers solvates and hydrates thereof. These compounds may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration intravenous spray parenteral lozenge solution syrup sachet transdermal administration or injection. Such compositions may be used to treatment of inflammation or its associated complications.
Soft Copy Submitted in pdf...
| # | Name | Date |
|---|---|---|
| 1 | 201947026629.pdf | 2019-07-03 |
| 2 | 201947026629-STATEMENT OF UNDERTAKING (FORM 3) [03-07-2019(online)].pdf | 2019-07-03 |
| 3 | 201947026629-REQUEST FOR EARLY PUBLICATION(FORM-9) [03-07-2019(online)].pdf | 2019-07-03 |
| 4 | 201947026629-PROOF OF RIGHT [03-07-2019(online)].pdf | 2019-07-03 |
| 5 | 201947026629-PRIORITY DOCUMENTS [03-07-2019(online)].pdf | 2019-07-03 |
| 6 | 201947026629-POWER OF AUTHORITY [03-07-2019(online)].pdf | 2019-07-03 |
| 7 | 201947026629-FORM-9 [03-07-2019(online)].pdf | 2019-07-03 |
| 8 | 201947026629-FORM FOR SMALL ENTITY(FORM-28) [03-07-2019(online)].pdf | 2019-07-03 |
| 9 | 201947026629-FORM 1 [03-07-2019(online)].pdf | 2019-07-03 |
| 10 | 201947026629-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [03-07-2019(online)].pdf | 2019-07-03 |
| 11 | 201947026629-DRAWINGS [03-07-2019(online)].pdf | 2019-07-03 |
| 12 | 201947026629-DECLARATION OF INVENTORSHIP (FORM 5) [03-07-2019(online)].pdf | 2019-07-03 |
| 13 | 201947026629-COMPLETE SPECIFICATION [03-07-2019(online)].pdf | 2019-07-03 |
| 14 | Correspondence by Agent_ Form-1_08-07-2019.pdf | 2019-07-08 |
| 15 | 201947026629-FORM 3 [25-09-2019(online)].pdf | 2019-09-25 |
| 16 | 201947026629-OTHERS [04-11-2020(online)].pdf | 2020-11-04 |
| 17 | 201947026629-FORM FOR STARTUP [04-11-2020(online)].pdf | 2020-11-04 |
| 18 | 201947026629-EVIDENCE FOR REGISTRATION UNDER SSI [04-11-2020(online)].pdf | 2020-11-04 |
| 19 | 201947026629-FORM 18 [10-12-2020(online)].pdf | 2020-12-10 |
| 20 | 201947026629-RELEVANT DOCUMENTS [04-05-2021(online)].pdf | 2021-05-04 |
| 21 | 201947026629-FORM 13 [04-05-2021(online)].pdf | 2021-05-04 |
| 22 | 201947026629-OTHERS [29-07-2021(online)].pdf | 2021-07-29 |
| 23 | 201947026629-Information under section 8(2) [29-07-2021(online)].pdf | 2021-07-29 |
| 24 | 201947026629-FORM 3 [29-07-2021(online)].pdf | 2021-07-29 |
| 25 | 201947026629-FER_SER_REPLY [29-07-2021(online)].pdf | 2021-07-29 |
| 26 | 201947026629-DRAWING [29-07-2021(online)].pdf | 2021-07-29 |
| 27 | 201947026629-CORRESPONDENCE [29-07-2021(online)].pdf | 2021-07-29 |
| 28 | 201947026629-CLAIMS [29-07-2021(online)].pdf | 2021-07-29 |
| 29 | 201947026629-Annexure [29-07-2021(online)].pdf | 2021-07-29 |
| 30 | 201947026629-ABSTRACT [29-07-2021(online)].pdf | 2021-07-29 |
| 31 | 201947026629-FER.pdf | 2021-10-18 |
| 32 | 201947026629-US(14)-HearingNotice-(HearingDate-30-11-2021).pdf | 2021-10-29 |
| 33 | 201947026629-FORM-26 [26-11-2021(online)].pdf | 2021-11-26 |
| 34 | 201947026629-Correspondence to notify the Controller [26-11-2021(online)].pdf | 2021-11-26 |
| 35 | 201947026629-PETITION UNDER RULE 138 [13-12-2021(online)].pdf | 2021-12-13 |
| 36 | 201947026629-Written submissions and relevant documents [07-01-2022(online)].pdf | 2022-01-07 |
| 37 | 201947026629-Annexure [07-01-2022(online)].pdf | 2022-01-07 |
| 38 | 201947026629-PatentCertificate21-10-2022.pdf | 2022-10-21 |
| 39 | 201947026629-IntimationOfGrant21-10-2022.pdf | 2022-10-21 |
| 1 | SearchE_15-01-2021.pdf |